Searchable abstracts of presentations at key conferences in endocrinology

ea0077p27 | Bone and Calcium | SFEBES2021

An Audit into the Diagnosis and management of primary hyperparathyroidism

Zafar Muhammad , Singh Rajiv , Ogunko Arthur , Manghat Padmini , Abedo Itopa

Background: Primary Hyperparathyroidism is a leading cause of hypercalcaemia and is frequently asymptomatic. Due to its long-term complications, early diagnosis and management is essential. NICE published guidelines on diagnosis and management of Primary Hyperparathyroidism in May 2019. The aim of this audit was to compare our existing practices against NICE guidance.Methods: We conducted retrospective data collection by identifying patients diagnosed wi...

ea0074ncc68 | Highlighted Cases | SFENCC2021

An interesting case of pan-hypopituitarism associated with empty sella syndrome

Singh Rajiv , Ogunko Arthur , Mohandas Cynthia , Abedo Itopa

Background: Empty Sella syndrome (ESS) is caused by the herniation of the subarachnoid space into the sella turcica, causing compression of the pituitary gland. Patients may be asymptomatic or exhibit different degrees of pituitary hormone deficiency. Pan-hypopituitarism can occur if there is decreased or absent secretion of all of the anterior pituitary hormones. Case: We report the case of a 68 year old female of Pakistani background who was visiting t...

ea0032p102 | Bone and Osteoporosis | ECE2013

Effect of long-term valproate therapy on bone health parameters

Jyotsna V P , Singla Rajiv , Singh M B , Suma S V , Gupta Nandita

Introduction: Anti-epileptic drugs (AED) adversely affecting bone health. However, individual variations between different AEDs exist and not all AEDs are equally toxic to the bone. There is almost equipoise about the effect of valproate on bone.Methods: We conducted a cross-sectional study assessing bone mineral density with dual energy X-ray absorptiometry at the hip and lumbar spine in 33 outpatients receiving valproate for ≥1 year and 36 health...